Affluent Medical SA

Paris Stock Exchange AFME.PA

Affluent Medical SA Operating Income for the year ending December 31, 2023: USD -14.42 M

Affluent Medical SA Operating Income is USD -14.42 M for the year ending December 31, 2023, a 5.68% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Affluent Medical SA Operating Income for the year ending December 31, 2022 was USD -15.29 M, a -1.50% change year over year.
Affluent Medical SA Operating Income for the year ending December 31, 2021 was USD -15.06 M, a 2.08% change year over year.
Affluent Medical SA Operating Income for the year ending December 31, 2020 was USD -15.38 M, a 10.31% change year over year.
Affluent Medical SA Operating Income for the year ending December 31, 2019 was USD -17.15 M, a -38.78% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Paris Stock Exchange: AFME.PA

Affluent Medical SA

CEO	Sebastien Ladet Ph.D.
IPO Date	June 14, 2021
Location	France
Headquarters	320, avenue Archimède
Employees	66
Sector	Technology
Industries 3D Printing Biotechnology Clinical Trials Composite Materials Medical Instruments Robotics

Description

Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

Key trends

Past 5 years